Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin calcium versus fosfomycin trometamol for uncomplicated urinary tract infection in adult women
2021-002911-72Phase 3Active
- Sponsor
- Laboratorios ERN
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fosfomycin in urinary tract infection (UTI) and cystitis (2 arms), sponsored by Laboratorios ERN. Primary endpoint: Primary clinical and microbiological response. Started Dec 2021; status: active.
02
Drugs
fosfomycin
03
Conditions
urinary tract infection (UTI)cystitis
Beyond the preview
Go deeper on 2021-002911-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002911-72.